Anti-VEGF-Antikörper
European patent · EP2851372 · In force
Register entry
- Publication number
- EP2851372
- Application number
- EP14191456
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Dec 1, 2008
- Published
- Mar 25, 2015
- Granted
- Feb 1, 2017
- Protection ends at the latest
- Nov 30, 2028
- Next annual fee due
- Dec 31, 2026
- IPC classes
- C07K 16/00 (2006.01)C07K 16/22 (2006.01)C07K 16/32 (2006.01)A61K 39/395 (2006.01)A61P 35/00 (2006.01)C12N 15/13 (2006.01)
- Priority
- US 991302 P 30.11.2007
- Divided from
- EP08857287
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jan 1, 2026
Change
Published in Swissreg on 01.01.2026
- Jan 1, 2025
Change
Published in Swissreg on 01.01.2025
- Jan 1, 2024
Change
Published in Swissreg on 01.01.2024
- Jan 1, 2023
Change
Published in Swissreg on 01.01.2023
- Mar 9, 2017
Agent entered
- Representative
- F. HOFFMANN-LA ROCHE AG, Grenzacherstrasse 124, 4070 Basel
Published in Swissreg on 09.03.2017
- Feb 1, 2017
Granted
Published in Swissreg on 01.02.2017
Parties
Inventor
Fuh, Germaine
Pacifica, CA 94044, US
Lee, Chingwei, V.
Foster City, CA 94404, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.